- Home
- PBYI vs MHF Comparison
PBYI vs MHF Comparison
Compare PBYI & MHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- MHF
- Stock Information
- Founded
- PBYI 2010
- MHF 1988
- Country
- PBYI United States
- MHF United States
- Employees
- PBYI N/A
- MHF N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- MHF Finance/Investors Services
- Sector
- PBYI Health Care
- MHF Finance
- Exchange
- PBYI Nasdaq
- MHF Nasdaq
- Market Cap
- PBYI 171.7M
- MHF 148.8M
- IPO Year
- PBYI N/A
- MHF N/A
- Fundamental
- Price
- PBYI $4.56
- MHF $7.19
- Analyst Decision
- PBYI Strong Buy
- MHF
- Analyst Count
- PBYI 1
- MHF 0
- Target Price
- PBYI $7.00
- MHF N/A
- AVG Volume (30 Days)
- PBYI 980.5K
- MHF 57.2K
- Earning Date
- PBYI 11-06-2025
- MHF 01-01-0001
- Dividend Yield
- PBYI N/A
- MHF 4.29%
- EPS Growth
- PBYI 434.29
- MHF N/A
- EPS
- PBYI 0.97
- MHF N/A
- Revenue
- PBYI $238,062,000.00
- MHF N/A
- Revenue This Year
- PBYI N/A
- MHF N/A
- Revenue Next Year
- PBYI N/A
- MHF N/A
- P/E Ratio
- PBYI $4.75
- MHF N/A
- Revenue Growth
- PBYI 8.63
- MHF N/A
- 52 Week Low
- PBYI $2.25
- MHF $5.92
- 52 Week High
- PBYI $6.07
- MHF $6.79
- Technical
- Relative Strength Index (RSI)
- PBYI 47.28
- MHF 65.84
- Support Level
- PBYI $4.93
- MHF $6.72
- Resistance Level
- PBYI $5.22
- MHF $7.34
- Average True Range (ATR)
- PBYI 0.32
- MHF 0.10
- MACD
- PBYI -0.10
- MHF 0.05
- Stochastic Oscillator
- PBYI 7.37
- MHF 75.81
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About MHF Western Asset Municipal High Income Fund Inc.
Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.